Last reviewed · How we verify
NCT05695885
STEPS Implementation Trial
NA trial testing STEPS in Autism Spectrum Disorder in 80 participants. Currently enrolling.
31 March 2025
Quick facts
| Lead sponsor | University of Alabama, Tuscaloosa |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 80 |
| Start date | 1 April 2023 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- STEPS
- Services as usual (SAU)
Conditions studied
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
Sponsor
University of Alabama, Tuscaloosa
Who can join
Adults 16 to 25, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will inform understanding of how to support emerging adults with autism spectrum disorder (ASD). The investigators will use a theoretically informed and research-based transition support program developed for people with ASD and test how effective it is when delivered by community agencies. Results will provide information on the effectiveness of the program as well as on mechanisms of change and contextual factors that promote or impede implementation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05695885
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of STEPS
Trials testing the same drug.
- NCT05278234 — STEPS: An Efficacy Trial of a Chronic Pain Self-Management Program for Older Adults · NA · active not recruiting
- NCT05581069 — Improving Outcomes in Autism: Community Implementation of Stepped Transition in Education Program · NA · unknown
- NCT02855008 — Steps to Effective Problem Solving in Group Homes · NA · completed
Other recruiting trials for Autism Spectrum Disorder
Currently open trials in the same condition.
- NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
- NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting
Other University of Alabama, Tuscaloosa trials
Trials by the same sponsor.
- NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
- NCT06864273 — Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama a · NA · recruiting
- NCT05632575 — The Virtual Promotoras Study: eHealth Intervention to Promote Sexual Health Among Young Latina Women in the US South · NA · completed
- NCT06076967 — Mindfulness Intervention for College Students With ADHD · NA · recruiting
- NCT05820919 — Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05695885 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alabama, Tuscaloosa
- Last refreshed: 16 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05695885.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing